Metabolic disposition of leukotriene B4 (LTB4) and oxidation‐resistant analogues of LTB4 in conscious rabbits
Authors:
Open Access
- 1 June 1994
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 112 (2) , 654-658
Abstract
The kinetics of leukotriene B4 (LTB4), after single i.v. injections of doses of 0.1 to 1 μg kg−1, were investigated in conscious rabbits and compared with those of the Ω‐ and β‐oxidation resistant bioactive analogues, 20, 20, 20‐trifluoro‐LTB4 (20‐F3‐LTB4) and 3‐thio‐LTB4, respectively. Immunoreactive LTB4 (IR‐LTB4) elimination was first‐order, as shown by a constant systemic clearance (ClLTB4) and a proportional increase in the area under the curve (AUC) of the plasma concentration versus time curve over the dose‐range studied. Our results showed a good correlation between observed steady‐state plasma concentrations (Css) of IR‐LTB4 after continuous infusion of LTB4 and those predicted by using the mean estimated ClLTB4 of 93 ± 4 ml min−1 kg−1, further confirming the linearity of IR‐LTB4 elimination. The half‐life (t½) or IR‐LTB4 increased from 0.47 ± 0.02 to 0.63 ± 0.04 min as a consequence of a change in the apparent volume of distribution (Vd) from 72 ± 5 to 109 ± 13 ml kg−1, for the 0.1 and 1 μg kg−1 doses injected, respectively. Single i.v. injections of [3H]‐LTB4 (4.7 ng kg−1) were administered, and the decay of plasma [3H]‐LTB4 following h.p.l.c. purification was used to estimate the kinetic parameters. The kinetic parameters of [3H]‐LTB4 were characterized by a mean systemic clearance (Cl) of 96 ± 11 ml min−1 kg−1, a t½ of 0.53 ± 0.03 min, and an apparent Vd of 85 ± 9 ml kg−1, similar to the parameters obtained after LTB4 boluses. The disposition of LTB4 analogues, whether resistant to β‐ or to β‐oxidation in vitro, did not differ significantly from the disposition of the LTB4 molecule. The half‐lives of 20‐F3‐LTB4 and 3‐thio‐LTB4 in the circulation were 0.52 ± 0.07 min and 0.70 ± 0.11 min, respectively. In summary, our results showed that LTB4, as well as Ω‐oxidation‐ and β‐oxidation‐resistant analogues were cleared very rapidly from the rabbit circulation and indicate that in situ, metabolism in blood is not a rate‐limiting factor for the elimination of LTB4.Keywords
This publication has 25 references indexed in Scilit:
- Eicosanoids and inflammatory bowel disease: Regulation and prospects for therapyProstaglandins, Leukotrienes and Essential Fatty Acids, 1990
- Direct and Neurohumoral Cardiovascular Effects of Atrial Natriuretic PeptideJournal of Cardiovascular Pharmacology, 1989
- Biosynthesis of 20,20,20-trifluoroleukotriene B4 from 20,20,20-trifluoroarachidonic acid: A metabolically stable analog of leukotriene B4 and its application to a study of stimulation of leukotriene B4 synthesis by immunoglobulin GArchives of Biochemistry and Biophysics, 1988
- Leukotriene B4 and 20-OH-LTB4 in purulent peritoneal exudates demonstrated by GC-MSProstaglandins, Leukotrienes and Medicine, 1986
- Leukotriene B4 production by stimulated whole blood: Comparative studies with isolated polymorphonuclear cellsBiochemical and Biophysical Research Communications, 1986
- Disappearance and metabolism of leukotriene B4 during carrageenan-induced pleurisyBiochemical Pharmacology, 1985
- Leukotriene B4 omega-hydroxylase in human polymorphonuclear leukocytes. Partial purification and identification as a cytochrome P-450.Journal of Clinical Investigation, 1985
- Metabolism of leukotriene B4 in hepatic microsomesBiochemical and Biophysical Research Communications, 1985
- Studies on leukotriene B4 ω-oxidation in human leukocytesCanadian Journal of Biochemistry and Cell Biology, 1984
- Metabolism of leukotriene B4 in the monkey. Identification of the principal nonvolatile metabolite in the urineProstaglandins, 1984